Approval · Notice of Compliance 4604 · 1996
OXYBUTYN: Notice of Compliance 4604
Issued May 8, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4604
- Date
- May 8, 1996
- Company
- Icn Canada Ltd.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Anticholinergic - antispasmodic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OXYBUTYN | 02220059 | Cancelled Post Market |
Medicinal ingredients
- OXYBUTYNIN CHLORIDE 5 MG per TAB